- Home
- HAIN vs TNYA Comparison
HAIN vs TNYA Comparison
Compare HAIN & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAIN
- TNYA
- Stock Information
- Founded
- HAIN 1993
- TNYA 2016
- Country
- HAIN United States
- TNYA United States
- Employees
- HAIN N/A
- TNYA N/A
- Industry
- HAIN Packaged Foods
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- HAIN Consumer Staples
- TNYA Health Care
- Exchange
- HAIN Nasdaq
- TNYA Nasdaq
- Market Cap
- HAIN 159.7M
- TNYA 189.1M
- IPO Year
- HAIN 1993
- TNYA 2021
- Fundamental
- Price
- HAIN $1.82
- TNYA $1.35
- Analyst Decision
- HAIN Hold
- TNYA Strong Buy
- Analyst Count
- HAIN 9
- TNYA 5
- Target Price
- HAIN $3.85
- TNYA $8.60
- AVG Volume (30 Days)
- HAIN 950.0K
- TNYA 4.4M
- Earning Date
- HAIN 11-06-2025
- TNYA 11-05-2025
- Dividend Yield
- HAIN N/A
- TNYA N/A
- EPS Growth
- HAIN N/A
- TNYA N/A
- EPS
- HAIN N/A
- TNYA N/A
- Revenue
- HAIN $1,615,231,000.00
- TNYA N/A
- Revenue This Year
- HAIN N/A
- TNYA N/A
- Revenue Next Year
- HAIN N/A
- TNYA N/A
- P/E Ratio
- HAIN N/A
- TNYA N/A
- Revenue Growth
- HAIN N/A
- TNYA N/A
- 52 Week Low
- HAIN $1.30
- TNYA $0.36
- 52 Week High
- HAIN $9.43
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- HAIN 54.60
- TNYA 72.70
- Support Level
- HAIN $1.72
- TNYA $1.05
- Resistance Level
- HAIN $1.87
- TNYA $1.25
- Average True Range (ATR)
- HAIN 0.10
- TNYA 0.14
- MACD
- HAIN 0.00
- TNYA 0.01
- Stochastic Oscillator
- HAIN 53.57
- TNYA 81.79
About HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.